Singapore, Mexico, Japan, Brazil and the United Kingdom. This site accounting shows significant changes from a 2016 self-description, which listed sixteen major sites. The presence in India was established in Genome Valley, where ground was broken in 2011. In 2018, Lonza opened a facility in the United States in Pearland, Texas (a suburb of Houston). This is one of four sites which are focused on cell and gene therapy, the other three being in Portsmouth, New Hampshire; Geleen, Netherlands; and Singapore. , the company has employed over 17,500 people, across about 35 countries. References External links Biotechnology companies of Switzerland Companies listed on the SIX Swiss Exchange Dual-listed companies Manufacturing companies based in Basel Manufacturing companies established in 1897 Multinational companies headquartered in Switzerland Pharmaceutical companies established in 1897 1897 establishments in Switzerland